amitriptyline has been researched along with Dominant Hereditary Sensory Neuropathy, Type III in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maiss, HJ | 1 |
| Witton, K | 1 |
2 other studies available for amitriptyline and Dominant Hereditary Sensory Neuropathy, Type III
| Article | Year |
|---|---|
[Therapy of psycho-autonomic and dysphoric syndromes in the general practice].
Topics: Adjustment Disorders; Adult; Amitriptyline; Anxiety; Bipolar Disorder; Chlordiazepoxide; Climacteric | 1968 |
Circulatory lability and depression.
Topics: Aged; Amitriptyline; Blood Pressure Determination; Depression; Dysautonomia, Familial; Humans; Hyper | 1966 |